ADR — Adherium Share Price
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapNeutral
- AU$14.94m
- AU$2.17m
- AU$3.34m
- 49
- 30
- 26
- 28
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.15 | ||
| Price to Tang. Book | 1.16 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.6 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -83.67% | ||
| Return on Equity | -93.52% | ||
| Operating Margin | -335.93% | ||
Financial Summary
| Year End 30th Jun | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 6.17 | 2.85 | 2.23 | 0.77 | 3.34 | n/a | n/a | 2.42% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Adherium Limited is a New Zealand-based respiratory e-health company. The Company is focused on patient adherence, remote monitoring and data management solutions for patients, physicians, payers and providers. The Company is a provider of integrated digital health solutions and connected respiratory medical devices. Its Hailie sensor technology and cloud-based data platform enables physicians and payers to optimally manage patients with difficult-to-treat and severe asthma and chronic obstructive pulmonary disease (COPD). Its Hailie solution includes a suite of integration tools to enable the capture and sharing of health data via mobile and desktop applications, software development kit (SDK) and application programming interface (API) integration tools, and its own range of sensors connected to respiratory medications. Its Hailie solution is designed to provide visibility to healthcare providers of medication use history to understand patterns in patient respiratory disease.
Directors
- James Ward-Lilley CHM (52)
- Rick Legleiter CEO (61)
- Robert Spurr CFO
- Geoff Feakes CTO
- Rob Turnbull VFN
- Timothy Houchin VPR
- Vik Panda VPR
- Julia Chambers OTH
- Nigel Devine OTH
- Jane Lapon OTH
- Bronwyn Le Grice OTH
- Chris Mander OTH
- Maggie Scott OTH
- Mark Licciardo SEC
- George Baran NED
- Jeremy Curnock-Cook NED (70)
- William Hunter NED
- Matthew McNamara NED
- Bruce McHarrie NID (55)
- Last Annual
- June 30th, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- April 17th, 2015
- Public Since
- August 26th, 2015
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 4,979,438,276
- Address
- Level 11, 16 Kingston Street, AUCKLAND, 1010
- Web
- https://www.adherium.com/
- Phone
- +64 93072771
- Auditors
- PricewaterhouseCoopers
Upcoming Events for ADR
Similar to ADR
4DMedical
Australian Stock Exchange - SEATS
Allegra Orthopaedics
Australian Stock Exchange - SEATS
Analytica
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
FAQ
What is the Adherium share price?
As of Today at 01:00 UTC, shares in Adherium are trading at AU$0.00. This share price information is delayed by 15 minutes.
How has the Adherium share price performed this year?
Shares in Adherium last closed at AU$0.00 and the price had moved by -62.5% over the past 365 days. In terms of relative price strength the Adherium share price has underperformed the ASX All Ordinaries Index by -62.51% over the past year.
What are the analyst and broker recommendations for Adherium?
The overall consensus recommendation for Adherium is Strong Sell. You can view the full broker recommendation list by unlocking its StockReport.
What is the Adherium dividend yield?
Adherium does not currently pay a dividend.
Does Adherium pay a dividend?
Adherium does not currently pay a dividend.
When does Adherium next pay dividends?
Adherium does not currently pay a dividend.
How do I buy Adherium shares?
To buy shares in Adherium you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Adherium?
As of the previous close price of AU$0.00, shares in Adherium had a market capitalisation of AU$14.94m.
Where are Adherium shares listed?
Here are the trading details for Adherium:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: ADR
What kind of share is Adherium?
Based on an overall assessment of its quality, value and momentum Adherium is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Adherium share price forecast for 2023?
The analyst consensus target price for shares in Adherium is AU$0.01. That is 233.33% above the last closing price of AU$0.00.
Analysts covering Adherium currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
What is the trend in the Adherium share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Adherium. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -24.11%.
As of the last closing price of AU$0.00, shares in Adherium were trading -49.09% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Adherium PE Ratio?
The Adherium PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Adherium?
Adherium's management team is headed by:
- James Ward-Lilley - CHM
- Rick Legleiter - CEO
- Robert Spurr - CFO
- Geoff Feakes - CTO
- Rob Turnbull - VFN
- Timothy Houchin - VPR
- Vik Panda - VPR
- Julia Chambers - OTH
- Nigel Devine - OTH
- Jane Lapon - OTH
- Bronwyn Le Grice - OTH
- Chris Mander - OTH
- Maggie Scott - OTH
- Mark Licciardo - SEC
- George Baran - NED
- Jeremy Curnock-Cook - NED
- William Hunter - NED
- Matthew McNamara - NED
- Bruce McHarrie - NID